Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial.
Rosenson, Robert S
Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial. [electronic resource] - Lancet (London, England) Feb 2009 - 649-58 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1474-547X
10.1016/S0140-6736(09)60403-7 doi
Cholesterol--blood
Coronary Disease--blood
Double-Blind Method
Enzyme Inhibitors--adverse effects
Female
Humans
Lipoproteins--blood
Male
Middle Aged
Phospholipases A2, Secretory--antagonists & inhibitors
Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial. [electronic resource] - Lancet (London, England) Feb 2009 - 649-58 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1474-547X
10.1016/S0140-6736(09)60403-7 doi
Cholesterol--blood
Coronary Disease--blood
Double-Blind Method
Enzyme Inhibitors--adverse effects
Female
Humans
Lipoproteins--blood
Male
Middle Aged
Phospholipases A2, Secretory--antagonists & inhibitors